Previous Recipients
- 2006
In September 2006, Craig C. Mello, a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, was named the inaugural recipient of The Dr. Paul Janssen Award. Mello was selected for his role in the discovery of RNA interference (RNAi) and the elucidation of its biological functions
- 2008
Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of The Kennedy Institute of Rheumatology, Imperial College London, received the 2008 Dr. Paul Janssen Award for their role in the discovery of tumor necrosis factor-alpha, or TNF-alpha, as an effective therapeutic target for rheumatoid arthritis and other autoimmune diseases.
- 2009
Axel Ullrich, Ph.D., director of the Department of Molecular Biology, Max Planck Institute of Biochemistry in Germany, received the 2009 Dr. Paul Janssen Award for his pioneering work in applying molecular biology and molecular cloning to the discovery of protein therapeutics for the treatment of a wide range of diseases, including diabetes and cancer. Basic research in Ullrich’s laboratory led to the characterization of several medically relevant receptors of the tyrosine kinase family, including receptors for epidermal growth factor and vascular endothelial growth factor. He demonstrated that these receptors are critically involved in human cancer and developed therapeutics based on these discoveries.
- 2010
Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases (NIAID) and Erik De Clercq, M.D., Ph.D., Professor Emeritus, Rega Institute for Medical Research were awarded the 2010 Dr. Paul Janssen Award. Dr. Fauci received the award for his pioneering contributions to basic and clinical research in the areas of AIDS and other immunodeficiencies, both as a scientist and through his service as the Director of the NIAID. Dr. De Clercq was recognized for his landmark discoveries in anti-HIV medications, including nucleotide analogues, and inventions or co-inventions of several approved drugs for anti-viral therapy.
- 2011
Napoleone Ferrara, M.D., Genentech Fellow, was selected as the 2011 Dr. Paul Janssen Award recipient for his research on angiogenesis, the process of new blood vessel formation that plays a key role in cancer proliferation and a number of other diseases. Dr. Ferrara’s discoveries opened the door to the development of a new class of therapeutics to combat a serious eye disorder and contributed to the development of new oncology therapeutics.
- 2012
Victor Ambros, Ph.D., of the University of Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General Hospital and Harvard Medical School, received the award for their collaborative discovery of microRNAs (miRNAs) as central regulators of gene expression and development
-
Panelists participate at the 2008 Dr. Paul Janssen Award for Biomedical Research Symposium at the New York Academy of Sciences in New York
Read more about this topic: Dr. Paul Janssen Award For Biomedical Research
Famous quotes containing the words previous and/or recipients:
“There was a deserted log camp here, apparently used the previous winter, with its “hovel” or barn for cattle.... It was a simple and strong fort erected against the cold, and suggested what valiant trencher work had been done there.”
—Henry David Thoreau (1817–1862)
“The proclamation and repetition of first principles is a constant feature of life in our democracy. Active adherence to these principles, however, has always been considered un-American. We recipients of the boon of liberty have always been ready, when faced with discomfort, to discard any and all first principles of liberty, and, further, to indict those who do not freely join with us in happily arrogating those principles.”
—David Mamet (b. 1947)